Clinical Trials Browser

Interventional × Carcinoma × CP protocol × Clear all

NCT03519971 2025-10-28

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

Phase 3 Active not recruiting

328 enrolled 23 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00894569 2009-05-14

PACET-CUP

Phase 2 Unknown

Carcinoma, Neoplasms, Unknown Primary